COVE R S TORY
Getinge’s Commitment
l Continuous implementation of ISO 14001 certifications or recertification of our manufacturing sites
l EcoDesign standards for product development
l Following Global Reporting Initiative (GRI)
l UN Global Compact member l Getinge Code of Conduct l Policies regarding environment, working conditions, anti-corruption and human rights
l Supporting the UN’s Sustainable Development Goals
The steriliser is designed to process a high volume of instruments in a short time – and since process time and media consumption is optimised for each load, the steriliser also reduces the environmental impact. The S-8668T was developed to increase reprocessing throughput within the Central Sterile Supply Department (CSSD). With the turbo multitasking technology available for the S-8668T model, processing time can be cut by up to 25% and thereby reduce overall consumption of energy, water and chemicals.
CO2 emissions
Equally important is Getinge’s work to significantly reduce its CO2
emissions in
production. Between 2010-2018 the direct and indirect emissions were reduced by 29% (ton CO2
target to become a CO2
/MSEK).To reach the new neutral company,
Getinge has set-up various activities. For example, switching to renewable energy sources (green electricity) and investments in green certifications, but equally important to update the vehicle fleet, travel routines and finding new and smart logistics alternatives. Getinge UK & Ireland will begin to transition to fully sustainable fleet operations. As of November 2020, the organisation will only provide fully electric and hybrid vehicles for its employees who drive company cars in an effort to drive its CO2
emissions down
by over 90%. It will also take this one step further by offering leasing options on electric cars for any non-field based employees, who do not currently receive a company car. “The decision to become all CO2
neutral
in five years is a natural step for us globally, and will be a big part of the UK & Ireland organisation’s operations,” says Avril Forde, managing director UK&I & president, North Europe. “We will continuously analyse, validate and add activities related to our environmental efforts to ensure we reach our target.”
NOVEMBER 2020
UN’s 17 Sustainable Development Goals Getinge supports all of the UN’s 17 Sustainable Development Goals (SDGs) for environmental, social and economically sustainable development, and Getinge commenced its work to analyse how the company can contribute in an optimal way to the achievement of the SDGs. Getinge identified a number of goals that best correspond to the company’s impact on its business environment.
These goals were: Goal 3 – Ensure healthy lives and promote well-being for all at all ages; Goal 4 – Ensure inclusive and quality education for all and promote lifelong learning; Goal 6 – Ensure availability and sustainable management of water and sanitation for all; Goal 8 – Promote inclusive and sustainable economic growth, employment and decent work for all; Goal 12 – Ensure sustainable consumption and production patterns.
Getinge’s activities to become CO2 neutral
will be externally validated through a third- party auditor, PwC.
About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimise workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating theatres, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.
For more information, contact Getinge UK & Ireland:
Email:
uk.marketing@
getinge.com Telephone: +44 (0) 1773 814730
WWW.CLINICALSERVICESJOURNAL.COM l 7
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100
